Skip to main content
  • 1662 Accesses

Abstract

Systemic sclerosis (SSc; scleroderma) is a poorly understood connective tissue disease that involves the skin, gastrointestinal tract, musculoskeletal system, kidneys, heart, and the lungs (Figures 20.1, 20.2, and 20.3). The earliest inflammatory changes occur in the microcirculation with endothelial cell activation, followed by perivascular infiltration of monocytes and lymphocytes. Subsequently, fibroblasts become activated and deposit increased extracellular matrix in affected tissue systems. There is evidence to support genetic factors in the development of SSc, but few candidate susceptibility or severity genes have yet been found.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Bibliography

  1. Veeraghavan S, Sharma O. Progressive systemic sclerosis and the lung. Curr Opin Pulm Med 1998;4:305–309.

    Article  Google Scholar 

  2. Schurawitzki H, Stiglbauer R, Graninger W, Herold C, Polzleitner D, Burghuber OC, Tscholakoff D. Interstitial lung disease in progressive systemic sclerosis: High resolution CT versus radiography. Radiology 1990;176:755–759.

    PubMed  CAS  Google Scholar 

  3. Johnson DA, Drane WE, Curran J, Cattau EL Jr, Ciarleglio C, Khan A, Cotelingam J, Benjamin SB. Pulmonary systemic sclerosis: A complication of gastro-esophageal reflux and occult aspiration. Arch Intern Med 1989;149:589–593.

    Article  PubMed  CAS  Google Scholar 

  4. Chang B, Wigley F, White B, Wise R. Scleroderma patients with combined pulmonary hypertension and interstitial lung disease. J Rheumatol 2003;30:2398–2405.

    PubMed  Google Scholar 

  5. Kim DS, Yoo B, Lee JS, Kim EK, Lim CM, Lee SD, Koh Y, Kim WS, Kim WD, Colby TV, Kitiaichi M. The major histopathologic pattern of pulmonary fibrosis in scleroderma is nonspecific interstitial pneumonia. Sarcoidosis Vasc Diffuse Lung Disease 2002;19:121–127.

    Google Scholar 

  6. Ho KT, Reveille JD. The clinical relevance of autoantibodies in scleroderma. Arthritis Res Ther 2003;5:80–93.

    PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag London Limited

About this chapter

Cite this chapter

(2006). Systemic Sclerosis and the Lung. In: Clinical Atlas of Interstitial Lung Disease. Springer, London. https://doi.org/10.1007/978-1-84628-326-0_20

Download citation

  • DOI: https://doi.org/10.1007/978-1-84628-326-0_20

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84628-320-8

  • Online ISBN: 978-1-84628-326-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics